Clinical Trial Update: Safety and PK Multi-dose Study of TAF/EVG Vaginal Insert [Phase 1]

View source ↗

Summary

A Phase 1 safety and pharmacokinetic study of a tenofovir alafenamide/elvitegravir vaginal insert has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• TAF/EVG Vaginal Insert (tenofovir alafenamide/elvitegravir vaginal insert)

Snippet

Sponsor: Eastern Virginia Medical School | Conditions: Safety Issues | Phase 1 | Status: COMPLETED